This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Niowave, Inc. | |
|---|---|
| Name | Niowave, Inc. |
| Type | Private |
| Founded | 2000 |
| Founder | Bob Kruschwitz |
| Headquarters | Lansing, Michigan, United States |
| Key people | Lawrence J. Jones |
| Industry | Particle accelerators, Medical isotopes, Radioisotopes |
| Products | Superconducting electron accelerators, Radioisotope production, Instrumentation |
Niowave, Inc. is an American company specializing in superconducting radio-frequency electron accelerator technology and radioisotope production for medical, industrial, and research applications. Founded in 2000 in Lansing, Michigan, the company develops compact linear accelerators, cryomodules, and isotope separation and production systems used by institutions in nuclear medicine, semiconductor inspection, and national laboratories. Niowave's work intersects with technologies and institutions spanning accelerator physics, radiochemistry, and healthcare instrumentation.
Niowave, Inc. was established in Lansing in 2000 by engineers and scientists with backgrounds at Lawrence Livermore National Laboratory, Fermi National Accelerator Laboratory, CERN, and Brookhaven National Laboratory, aiming to commercialize superconducting radio-frequency (SRF) electron accelerator technology. Early collaborations included contracts with National Aeronautics and Space Administration centers, partnerships with Michigan State University, and engagements with Los Alamos National Laboratory and Argonne National Laboratory for accelerator component testing. Over the 2000s and 2010s the company expanded from prototype cryomodule development to production of medical radioisotopes, working with organizations such as Oak Ridge National Laboratory, U.S. Department of Energy, and private healthcare firms. Niowave has been involved in technology transfer efforts with university technology offices like Purdue University Office of Technology Commercialization and partnerships reflecting ties to Duke University, Johns Hopkins University, and regional economic development agencies.
Niowave produces compact superconducting electron accelerators, cryomodules, and electron gun systems derived from SRF designs pioneered in facilities like SLAC National Accelerator Laboratory, DESY, and Thomas Jefferson National Accelerator Facility. Products include electron linacs for X-ray generation used in inspection systems similar to those developed by General Electric and Siemens Healthineers, as well as radioisotope production systems for isotopes such as those used in PET and SPECT imaging practiced at Mayo Clinic, Cleveland Clinic, and Massachusetts General Hospital. The company's technological portfolio draws on materials and fabrication techniques used at Oak Ridge National Laboratory, National Institute of Standards and Technology, and industrial partners in the supply chain such as Applied Materials and Lam Research.
Niowave's R&D programs have pursued improvements in SRF cavity design, cryogenic systems, and electron injector performance, referencing advances from Herman Winick-era synchrotron work and SRF research at Cornell University, University of Wisconsin–Madison, and Imperial College London. Research collaborations and funded projects have been associated with grants and cooperative agreements from U.S. Department of Energy, technology development organizations like DARPA, and healthcare research entities including National Institutes of Health programs. Projects have targeted production scalability for medical isotopes such as molybdenum-99 and actinium-225, linking to clinical trials and treatment centers like Johns Hopkins Hospital and radiopharmaceutical developers like Novartis and GE Healthcare subsidiaries.
Niowave operates manufacturing and laboratory facilities in Lansing, Michigan, hosting cleanrooms, cryogenic test stands, and hot cells for radiochemical processing—facilities comparable in function to those at Brookhaven National Laboratory and university-based isotope centers such as University of Missouri Research Reactor. Operations have included assembly and testing of SRF cryomodules, electron guns, and isotope separation apparatus with quality assurance practices informed by standards used at NASA Glenn Research Center and industrial partners like Boeing and Lockheed Martin. The company has also engaged with regional infrastructure stakeholders including Michigan Economic Development Corporation and local utilities.
Niowave has entered collaborative agreements and contracts with national laboratories and commercial entities, involving groups such as Los Alamos National Laboratory, Oak Ridge National Laboratory, Argonne National Laboratory, and academic partners at Michigan State University, University of Michigan, and Pennsylvania State University. Commercial partnerships have linked the company to medical and industrial firms including GE Healthcare, Siemens Healthineers, and specialty radiopharmaceutical companies, as well as to venture and investment entities aligned with Kaiser Permanente-adjacent health technology networks and regional incubators like TechTown Detroit.
Niowave targets markets in medical isotope supply chains supporting PET and targeted alpha therapy, industrial inspection using high-energy X-rays, and research instrumentation for universities and national laboratories. Customers and end-users include hospital systems such as Mayo Clinic, Cleveland Clinic, and research reactors that historically sourced isotopes from suppliers like Idaho National Laboratory and international producers in Canada and Europe. The company’s commercialization strategy reflects shifts in global isotope supply driven by outages at reactors like NRU and policy initiatives by agencies such as U.S. Department of Health and Human Services to encourage domestic production.
Niowave’s operations intersect with regulatory frameworks administered by agencies and authorities including the Nuclear Regulatory Commission, the Food and Drug Administration, and state-level radiological control programs in Michigan. Licensing, shipment, and clinical use of produced radioisotopes involve compliance with standards and guidance from organizations such as the International Atomic Energy Agency, American College of Radiology, and accreditation bodies linked to Joint Commission-certified hospitals. The company has navigated contractual, intellectual property, and procurement processes common in dealings with U.S. Department of Energy laboratories and private healthcare providers.
Category:Companies based in Lansing, Michigan